Clinical Trials Logo

Clinical Trial Summary

To prove the non-inferiority of the fixed timolol-dorzolamide combination (Cosopt) compared to 0.005% latanoprost (Xalatan) in the aspects of intraocular pressure (IOP) and ocular perfusion pressure (OPP) in subjects with normal tension glaucoma (NTG)

Clinical hypotheses. Primary hypothesis

- Cosopt group is non-inferior to Xalatan group in diurnal IOP reduction.

Secondary hypothesis

- Cosopt group is non-inferior to Xalatan group in diurnal diastolic and systolic OPP.


Clinical Trial Description

Cosopt (dorzolamide/timolol fixed combination) has well known effect for IOP reduction in POAG and OHT.3-5 However, there is no study about the effect and safety of Cosopt in NTG, Cosopt is not used the first line drug in the management of NTG.

In Korea, the prevalence of NTG is higher than western countries, the majority (about 80-90%) of open angle glaucoma patients have an IOP of 21 mmHg or less, so the study of NTG is important and searching of effective drug for the treatment of NTG is necessary.

In this study, we would prove the non-inferiority of Cosopt compared to Xalatan,6 which is used as a first line drug in the management of NTG, in the aspects of IOP and OPP including diastolic OPP (DOPP).

A prospective, interventional, randomized, crossover, single masked, single center study. Forty-four NTG patients were randomly allocated to one of two groups. Patients in group A were treated with Cosopt, lubricant, and Xalatan for 4 weeks each, whereas patients in group B were treated with Xalatan, lubricant, and Cosopt for 4 weeks each.

Recruit NTG patients, who are not treated with the glaucoma medication recent 2 months. If treated, after washout period of 4 weeks, the patients can be included in the study. Baseline IOP, systolic and diastolic BP will be measured. (Day 1) After 4 weeks of treatment of Cosopt or Xalatan, all participants will be checked diurnal IOP, systolic and diastolic BP. IOP was measured by Goldmann applanation tonometry (mean of three consecutive readings) with the patient in a sitting position at the slit lamp. Every IOP will be measured by one masked glaucoma specialist who is unaware of the treatment assignments. After the IOP measurements, after a 5-minite rest, pulse rate and BP (systolic and diastolic) of radial artery were measured in the sitting position using a standard automated blood pressure cuff. During the period, all measuring instruments keep to be calibrated by the manufacturer's instruction.

- OPP was calculated according to the following formula: OPP=(1/3 systolic BP + 2/3 diastolic BP) x 2/3 -IOP, diastolic OPP (DOPP)=diastolic BP-IOP. During the 4 weeks washout period, subjects will use lubricants.(Week 8) In this crossover study, with the other eye drops, the same measurement will be performed. (Week 12) ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01175902
Study type Interventional
Source The Catholic University of Korea
Contact
Status Completed
Phase N/A
Start date March 2011
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT01995136 - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 4
Completed NCT00706056 - A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure N/A
Not yet recruiting NCT05075369 - Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma N/A
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Recruiting NCT01446497 - Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma Phase 4
Terminated NCT01864317 - Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging Phase 2
Not yet recruiting NCT00739154 - Protective Effect of Phenytoin on Glaucoma N/A
Recruiting NCT03761992 - Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG N/A
Recruiting NCT05371977 - Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma N/A
Completed NCT03106532 - Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma Phase 2
Completed NCT01488032 - Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma N/A
Completed NCT00570362 - Systemic Glutathione Level in Normal Tension Glaucoma N/A
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Completed NCT02863705 - Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) Phase 4
Completed NCT00175786 - Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma N/A
Completed NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Phase 4
Completed NCT04014933 - Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
Recruiting NCT01794442 - Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins N/A
Completed NCT01802463 - Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma N/A
Unknown status NCT01795014 - Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma N/A